LRLR
General Information
DRACP ID DRACP01073
Peptide Name LRLR
Sequence LRLRLRLRLRLR
Sequence Length 12
UniProt ID Not available
PubChem CID Not available
Origin cationic amphiphilic peptides
Type Synthetic peptide
Classification
Active ACP
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
HCT 116 | Colon carcinoma | Carcinoma | IC50=31.8±2.9 µM | MTT assay | 72h | 1 |
HeLa | Human papillomavirus-related endocervical adenocarcinoma | Carcinoma | IC50>40 µM | MTT assay | 72h | 1 |
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity HDF: IC50=22.7±2.4 µM
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C72H140N30O13
Absent amino acids ACDEFGHIKMNPQSTVWY
Common amino acids LR
Mass 183048
Pl 13.2
Basic residues 6
Acidic residues 0
Hydrophobic residues 6
Net charge 6
Boman Index -6000
Hydrophobicity -35
Aliphatic Index 195
Half Life
Mammalian: 5.5 hour
Yeast: 3 min
E.coli: 2 min
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 0
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 34715505
Title Correlation between the secondary structure and surface activity of β-sheet forming cationic amphiphilic peptides and their anticancer activity
Doi 10.1016/j.colsurfb.2021.112165
Year 2022
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available